Cargando…

Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study

INTRODUCTION: The occurrence of metastasis is a threat to patients with colon cancer (CC), and the liver is the most common metastasis organ. However, the role of the extrahepatic organs in patients with liver metastasis (LM) has not been distinctly demonstrated. Therefore, this research aimed to ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Shuheng, Chen, Ling, Zhu, Guixian, Xuan, Wang, Hu, Fengyuan, Liu, Wanyi, Li, Wenyang, Lan, Ning, Chen, Min, Yan, Yanli, Li, Rong, Yang, Yiping, Ren, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280983/
https://www.ncbi.nlm.nih.gov/pubmed/37346071
http://dx.doi.org/10.3389/fonc.2023.1172670
_version_ 1785060919453155328
author Bai, Shuheng
Chen, Ling
Zhu, Guixian
Xuan, Wang
Hu, Fengyuan
Liu, Wanyi
Li, Wenyang
Lan, Ning
Chen, Min
Yan, Yanli
Li, Rong
Yang, Yiping
Ren, Juan
author_facet Bai, Shuheng
Chen, Ling
Zhu, Guixian
Xuan, Wang
Hu, Fengyuan
Liu, Wanyi
Li, Wenyang
Lan, Ning
Chen, Min
Yan, Yanli
Li, Rong
Yang, Yiping
Ren, Juan
author_sort Bai, Shuheng
collection PubMed
description INTRODUCTION: The occurrence of metastasis is a threat to patients with colon cancer (CC), and the liver is the most common metastasis organ. However, the role of the extrahepatic organs in patients with liver metastasis (LM) has not been distinctly demonstrated. Therefore, this research aimed to explore the prognostic value of extrahepatic metastases (EHMs). METHODS: In this retrospective study, a total of 13,662 colon patients with LM between 2010 and 2015 were selected from the Surveillance, Epidemiology, and End Results database (SEER). Fine and Gray’s analysis and K–M survival analysis were utilized to explore the impacts of the number of sites of EHMs and different sites of EHMs on prognosis. Finally, a prognostic nomogram model based on the number of sites of EHMs was constructed, and a string of validation methods was conducted, including concordance index (C-index), receiver operating characteristic curves (ROC), and decision curve analysis (DCA). RESULTS: Patients without EHMs had better prognoses in cancer-specific survival (CSS) and overall survival (OS) than patients with EHMs (p < 0.001). Varied EHM sites of patients had different characteristics of primary location site, grade, and histology. Cumulative incidence rates for CSS surpassed that for other causes in patients with 0, 1, 2, ≥ 3 EHMs, and the patients with more numbers of sites of EHMs revealed worse prognosis in CSS (p < 0.001). However, patients with different EHM sites had a minor difference in cumulative incidence rates for CSS (p = 0.106). Finally, a nomogram was constructed to predict the survival probability of patients with EHMs, which is based on the number of sites of EHMs and has been proven an excellent predictive ability. CONCLUSION: The number of sites of EHMs was a significant prognostic factor of CC patients with LM. However, the sites of EHMs showed limited impact on survival. Furthermore, a nomogram based on the number of sites of EHMs was constructed to predict the OS of patients with EHMs accurately.
format Online
Article
Text
id pubmed-10280983
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102809832023-06-21 Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study Bai, Shuheng Chen, Ling Zhu, Guixian Xuan, Wang Hu, Fengyuan Liu, Wanyi Li, Wenyang Lan, Ning Chen, Min Yan, Yanli Li, Rong Yang, Yiping Ren, Juan Front Oncol Oncology INTRODUCTION: The occurrence of metastasis is a threat to patients with colon cancer (CC), and the liver is the most common metastasis organ. However, the role of the extrahepatic organs in patients with liver metastasis (LM) has not been distinctly demonstrated. Therefore, this research aimed to explore the prognostic value of extrahepatic metastases (EHMs). METHODS: In this retrospective study, a total of 13,662 colon patients with LM between 2010 and 2015 were selected from the Surveillance, Epidemiology, and End Results database (SEER). Fine and Gray’s analysis and K–M survival analysis were utilized to explore the impacts of the number of sites of EHMs and different sites of EHMs on prognosis. Finally, a prognostic nomogram model based on the number of sites of EHMs was constructed, and a string of validation methods was conducted, including concordance index (C-index), receiver operating characteristic curves (ROC), and decision curve analysis (DCA). RESULTS: Patients without EHMs had better prognoses in cancer-specific survival (CSS) and overall survival (OS) than patients with EHMs (p < 0.001). Varied EHM sites of patients had different characteristics of primary location site, grade, and histology. Cumulative incidence rates for CSS surpassed that for other causes in patients with 0, 1, 2, ≥ 3 EHMs, and the patients with more numbers of sites of EHMs revealed worse prognosis in CSS (p < 0.001). However, patients with different EHM sites had a minor difference in cumulative incidence rates for CSS (p = 0.106). Finally, a nomogram was constructed to predict the survival probability of patients with EHMs, which is based on the number of sites of EHMs and has been proven an excellent predictive ability. CONCLUSION: The number of sites of EHMs was a significant prognostic factor of CC patients with LM. However, the sites of EHMs showed limited impact on survival. Furthermore, a nomogram based on the number of sites of EHMs was constructed to predict the OS of patients with EHMs accurately. Frontiers Media S.A. 2023-06-06 /pmc/articles/PMC10280983/ /pubmed/37346071 http://dx.doi.org/10.3389/fonc.2023.1172670 Text en Copyright © 2023 Bai, Chen, Zhu, Xuan, Hu, Liu, Li, Lan, Chen, Yan, Li, Yang and Ren https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Bai, Shuheng
Chen, Ling
Zhu, Guixian
Xuan, Wang
Hu, Fengyuan
Liu, Wanyi
Li, Wenyang
Lan, Ning
Chen, Min
Yan, Yanli
Li, Rong
Yang, Yiping
Ren, Juan
Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study
title Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study
title_full Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study
title_fullStr Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study
title_full_unstemmed Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study
title_short Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study
title_sort prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280983/
https://www.ncbi.nlm.nih.gov/pubmed/37346071
http://dx.doi.org/10.3389/fonc.2023.1172670
work_keys_str_mv AT baishuheng prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy
AT chenling prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy
AT zhuguixian prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy
AT xuanwang prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy
AT hufengyuan prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy
AT liuwanyi prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy
AT liwenyang prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy
AT lanning prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy
AT chenmin prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy
AT yanyanli prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy
AT lirong prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy
AT yangyiping prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy
AT renjuan prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy